Related Experiment Video
Updated: Jul 11, 2026
11:05
Behavioral Characterization of an Angelman Syndrome Mouse Model
Published on: October 20, 2023
Epilepsy in Angelman syndrome.
Karine Pelc1, Stewart G Boyd, Guy Cheron
1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium.
Seizure
|October 2, 2007
Summary
Angelman syndrome, a neurogenetic disorder, frequently causes epilepsy due to UBE3A gene absence. Understanding its pathophysiology may improve difficult epilepsy management in affected individuals.
Area of Science:
- Neurogenetics
- Epileptology
- Developmental Disorders
Background:
- Angelman syndrome is a rare neurogenetic disorder.
- It results from the absence of UBE3A gene expression from the maternal chromosome 15.
- Over 90% of individuals with Angelman syndrome experience epilepsy, often with atypical absence and myoclonic seizures.
Purpose of the Study:
- To summarize the key features of epilepsy in Angelman syndrome.
- To discuss current hypotheses regarding the pathophysiology of epilepsy in this condition.
- To highlight the challenges in managing epilepsy in Angelman syndrome.
Main Methods:
- Review of existing literature on Angelman syndrome and epilepsy.
- Analysis of seizure types and their prevalence.
- Discussion of proposed pathophysiological mechanisms.
Main Results:
- Epilepsy is a near-universal feature of Angelman syndrome, manifesting with diverse seizure types.
- Non-convulsive status epilepticus is frequently observed.
- Epilepsy often persists into adulthood, posing management difficulties.
Conclusions:
- The pathophysiology of Angelman syndrome epilepsy may involve impaired inhibitory transmission due to UBE3A deficiency affecting GABAA receptors and hippocampal CaMKII activity.
- Improved understanding of these mechanisms is crucial for developing better therapeutic strategies.
- Effective management of epilepsy in Angelman syndrome remains a significant clinical challenge.
Related Concept Videos
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...